Bioimpedance Analysis as Early Predictor for Clot Formation Inside a Blood-Perfused Test Chamber: Proof of Concept Using an In Vitro Test-Circuit.
bioimpedance analysis
clot detection
coagulation
in vitro test circuit
membrane oxygenator
sensor fibers
Journal
Biosensors
ISSN: 2079-6374
Titre abrégé: Biosensors (Basel)
Pays: Switzerland
ID NLM: 101609191
Informations de publication
Date de publication:
17 Mar 2023
17 Mar 2023
Historique:
received:
15
02
2023
revised:
08
03
2023
accepted:
15
03
2023
medline:
30
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
Clot formation inside a membrane oxygenator (MO) due to blood-to-foreign surface interaction represents a frequent complication during extracorporeal membrane oxygenation. Since current standard monitoring methods of coagulation status inside the MO fail to detect clot formation at an early stage, reliable sensors for early clot detection are in demand to reduce associated complications and adverse events. Bioimpedance analysis offers a monitoring concept by integrating sensor fibers into the MO. Herein, the feasibility of clot detection via bioimpedance analysis is evaluated. A custom-made test chamber with integrated titanium fibers acting as sensors was perfused with heparinized human whole blood in an in vitro test circuit until clot formation occurred. The clot detection capability of bioimpedance analysis was directly compared to the pressure difference across the test chamber (ΔP-TC), analogous to the measurement across MOs (ΔP-MO), the clinical gold standard for clot detection. We found that bioimpedance measurement increased significantly 8 min prior to a significant increase in ΔP-TC, indicating fulminant clot formation. Experiments without clot formation resulted in a lack of increase in bioimpedance or ΔP-TC. This study shows that clot detection via bioimpedance analysis under flow conditions in a blood-perfused test chamber is generally feasible, thus paving the way for further investigation.
Identifiants
pubmed: 36979606
pii: bios13030394
doi: 10.3390/bios13030394
pmc: PMC10046027
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : German Research Foundation
ID : DFG RO 2000/25-2
Références
J Artif Organs. 2021 Mar;24(1):15-21
pubmed: 32638141
Haematologica. 2013 Apr;98(4):549-54
pubmed: 23100275
Materials (Basel). 2014 Dec 19;7(12):8168-8188
pubmed: 28788296
N Engl J Med. 2018 May 24;378(21):1965-1975
pubmed: 29791822
Am J Cardiol. 2006 Jun 15;97(12):1713-7
pubmed: 16765119
Artif Organs. 2019 Feb;43(2):159-166
pubmed: 30084492
Membranes (Basel). 2022 Jan 06;12(1):
pubmed: 35054599
PLoS One. 2018 Jun 1;13(6):e0198392
pubmed: 29856834
Anal Chem. 2015 Oct 6;87(19):10072-9
pubmed: 26368847
Lancet. 2021 Oct 2;398(10307):1230-1238
pubmed: 34599878
Blood. 1981 Feb;57(2):199-202
pubmed: 6160890
PLoS One. 2014 Dec 02;9(12):e112316
pubmed: 25464516
Expert Rev Med Devices. 2008 Mar;5(2):239-61
pubmed: 18331184
JAMA. 2009 Nov 4;302(17):1888-95
pubmed: 19822628
Perfusion. 2017 May;32(4):301-305
pubmed: 27881701
Methodist Debakey Cardiovasc J. 2018 Apr-Jun;14(2):110-119
pubmed: 29977467
J Clin Invest. 1989 Jul;84(1):18-27
pubmed: 2661588
Crit Care. 2020 Jan 20;24(1):19
pubmed: 31959232
J Thromb Haemost. 2015 Jun;13 Suppl 1:S336-42
pubmed: 26149045
Lancet Respir Med. 2019 Feb;7(2):163-172
pubmed: 30642776
Perfusion. 2018 May;33(1_suppl):51-56
pubmed: 29788838
Lancet. 2020 Oct 10;396(10257):1071-1078
pubmed: 32987008
J Clin Med. 2022 Feb 24;11(5):
pubmed: 35268314
J Thromb Haemost. 2015 Jun;13 Suppl 1:S72-81
pubmed: 26149053
Physiol Meas. 2014 Jun;35(6):1163-80
pubmed: 24845882
Crit Care. 2021 Jun 14;25(1):211
pubmed: 34127027
Blood. 1999 Dec 15;94(12):4186-94
pubmed: 10590063
Crit Care Med. 2021 Mar 1;49(3):437-448
pubmed: 33555777